Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

ABL Bio Inc. Anti-4-1BB Antibody Patent Publication

The European Patent Office has published patent application EP3887403A1 by ABL Bio Inc. for an anti-4-1BB antibody and its use. This publication relates to intellectual property protection for novel therapeutic agents.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent EP3893930A1: Monoclonal Antibodies Against Human Dickkopf3

The European Patent Office has published patent application EP3893930A1 concerning monoclonal antibodies against human Dickkopf3 and their uses. The patent was published on March 11, 2026, with the Board of Regents, The University of Texas System listed as the applicant.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Bulletin: WT1 Peptides for Preventing Polyposis

The European Patent Office has published patent application EP3865146A1 concerning WT1 peptides and analogs for preventing or treating familial adenomatous polyposis and non-hereditary colorectal adenoma. The application lists the International Institute of Cancer Immunology, Inc. as the applicant.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication EP4004028A1: Relaxin Analogs

The European Patent Office has published patent application EP4004028A1 concerning relaxin analogs and methods of use, filed by Eli Lilly and Company. This publication provides notice of the patent application's details and designated states.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Antigen-binding protein constructs

The European Patent Office has published patent application EP3996817A1 concerning antigen-binding protein constructs and their uses, filed by Mythic Therapeutics, Inc. The publication date is March 11, 2026.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Anti-Gal3 antibodies and uses patent EP3918323A2

Anti-Gal3 antibodies and uses patent EP3918323A2

Routine Notice
Favicon for changeflow.com

HEYBOT Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark HEYBOT, filed on December 3, 2024. The application covers various audio speaker and headphone products. This filing initiates the trademark registration process.

Routine Notice Intellectual Property
Favicon for changeflow.com

SIVANEUR Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark SIVANEUR. The application covers a wide range of goods and services, including downloadable video game software, educational services, fabric, bar and restaurant services, investment advice, software as a service, academic research, social media marketing, and tabletop games.

Routine Notice Intellectual Property
Favicon for changeflow.com

LIGHTERA Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark LIGHTERA, filed on December 5, 2024. The application covers a wide range of telecommunications products, including fiber optic cables and connectors, as well as retail store services for electronics and refurbished telecommunications equipment.

Routine Notice Intellectual Property
Favicon for changeflow.com

USPTO Trademark Application for ADVENTURES OF SURFER JOE

The USPTO has received an intent-to-use trademark application for "ADVENTURES OF SURFER JOE" (TM98891113). The application covers online non-downloadable and downloadable movies, television shows, and webisodes featuring extreme sports, as well as printed books, graphic novels, comic books, decals, stickers, and posters.

Routine Notice Intellectual Property

Showing 12671–12680 of 38,851 changes

1 1266 1267 1268 1269 1270 3886

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.